Source: Pharmacy Times articles
Omalizumab expands its role in allergy management, now FDA-approved for food allergies, showcasing potential for broader applications in allergic rhinitis.
Read More
by MM360 Staff | May 16, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Omalizumab expands its role in allergy management, now FDA-approved for food allergies, showcasing potential for broader applications in allergic rhinitis.
Read More